US drugmaker AbbVie has entered a multi-year collaboration with Iambic, the US clinical-stage life sciences and technology company, to apply the latter firm's AI-driven discovery platform to small ...

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced positive top-line results for its registration-enabling VISTA trial evaluating laruparetigene zovaparvovec ...

Australian biotech company Telix Pharmaceuticals today announced it has signed a strategic agreement to lead a merger with ...

The US Food and Drug Administration (FDA) has accepted Insmed’s supplemental New Drug Application (sNDA) for review of Arikayce (amikacin liposome inhalation suspension) for the treatment of ...

US pharma giant Merck & Co said Japan's Ministry of Health, Labor and Welfare has approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) for subcutaneous use across all indications ...

German family-owned drugmaker Grünenthal today announced an agreement with Bayer to acquire Stivarga (regorafenib), an oral ...

Pharmacies in Denmark would be able to hand out an alternative pack of a medicine during a supply squeeze without first ...

Canadian neuroscience specialist Xenon Pharmaceuticals saw its shares fall more than 30% on Friday after it disclosed a voluntary pause in enrollment of new patients across its ongoing clinical ...

US clinical-stage biotech Electra Therapeutics (Nasdaq: ETRA) raised $350 million in an upsized initial public offering ...

French genetic medicines company Cyllene Therapeutics has appointed Dr Marc Grasso as executive vice president and chief financial officer (CFO).

Swedish pharmaceutical exports continue to grow. During the first half of 2026, pharmaceuticals worth 84.2 billion kronor ($8.57 billion) were exported – corresponding to 7.8% of Sweden's total ...

China has set a target for domestically developed first-in-class drugs to account for at least 25% of the global total by ...